These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36531184)

  • 1. Endothelial deletion of the cytochrome P450 reductase leads to cardiac remodelling.
    Lopez M; Malacarne PF; Ramanujam DP; Warwick T; Müller N; Hu J; Dewenter M; Weigert A; Günther S; Gilsbach R; Engelhardt S; Brandes RP; Rezende F
    Front Physiol; 2022; 13():1056369. PubMed ID: 36531184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of Endothelial Cytochrome P450 Reductase Induces Vascular Dysfunction in Mice.
    Malacarne PF; Ratiu C; Gajos-Draus A; Müller N; Lopez M; Pflüger-Müller B; Ding X; Warwick T; Oo J; Siragusa M; Angioni C; Günther S; Weigert A; Geißlinger G; Lütjohann D; Schunck WH; Fleming I; Brandes RP; Rezende F
    Hypertension; 2022 Jun; 79(6):1216-1226. PubMed ID: 35354305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epoxyeicosatrienoic Acid and Prostanoid Crosstalk at the Receptor and Intracellular Signaling Levels to Maintain Vascular Tone.
    Malacarne PF; Bezzenberger J; Lopez M; Warwick T; Müller N; Brandes RP; Rezende F
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of microsomal cytochrome P450 mono-oxygenase by Ca2+ store depletion and its contribution to Ca2+ entry in porcine aortic endothelial cells.
    Hoebel BG; Kostner GM; Graier WF
    Br J Pharmacol; 1997 Aug; 121(8):1579-88. PubMed ID: 9283690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular biotransformation of organic nitrates is independent of cytochrome P450 monooxygenases.
    Lopez M; Malacarne PF; Gajos-Draus A; Ding X; Daiber A; Lundberg JO; Offermanns S; Brandes RP; Rezende F
    Br J Pharmacol; 2021 Apr; 178(7):1495-1506. PubMed ID: 33450066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both cardiomyocyte and endothelial cell Nox4 mediate protection against hemodynamic overload-induced remodelling.
    Zhang M; Mongue-Din H; Martin D; Catibog N; Smyrnias I; Zhang X; Yu B; Wang M; Brandes RP; Schröder K; Shah AM
    Cardiovasc Res; 2018 Mar; 114(3):401-408. PubMed ID: 29040462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response.
    Nayeem MA; Hanif A; Geldenhuys WJ; Agba S
    Pharmacol Ther; 2022 Dec; 240():108213. PubMed ID: 35597366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional deletion of cytochrome P450 oxidoreductase in the liver and gastrointestinal tract: a new model for studying the functions of the P450 system.
    Finn RD; McLaren AW; Carrie D; Henderson CJ; Wolf CR
    J Pharmacol Exp Ther; 2007 Jul; 322(1):40-7. PubMed ID: 17435107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of renal cytochrome P450 enzymes to kidney endothelial dysfunction and vascular oxidative stress in obesity.
    Muñoz M; López-Oliva E; Pinilla E; Rodríguez C; Martínez MP; Contreras C; Gómez A; Benedito S; Sáenz-Medina J; Rivera L; Prieto D
    Biochem Pharmacol; 2022 Jan; 195():114850. PubMed ID: 34822809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
    Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
    J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented endothelial l-arginine transport ameliorates pressure-overload-induced cardiac hypertrophy.
    Rajapakse NW; Johnston T; Kiriazis H; Chin-Dusting JP; Du XJ; Kaye DM
    Exp Physiol; 2015 Jul; 100(7):796-804. PubMed ID: 25958845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disruption of invariant natural killer T cells exacerbates cardiac hypertrophy and failure caused by pressure overload in mice.
    Takahashi M; Kinugawa S; Takada S; Kakutani N; Furihata T; Sobirin MA; Fukushima A; Obata Y; Saito A; Ishimori N; Iwabuchi K; Tsutsui H
    Exp Physiol; 2020 Mar; 105(3):489-501. PubMed ID: 31957919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of soluble guanylyl cyclase (sGC) by riociguat attenuates heart failure and pathological cardiac remodelling.
    Rüdebusch J; Benkner A; Nath N; Fleuch L; Kaderali L; Grube K; Klingel K; Eckstein G; Meitinger T; Fielitz J; Felix SB
    Br J Pharmacol; 2022 Jun; 179(11):2430-2442. PubMed ID: 33247945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial deletion of protein tyrosine phosphatase-1B protects against pressure overload-induced heart failure in mice.
    Gogiraju R; Schroeter MR; Bochenek ML; Hubert A; Münzel T; Hasenfuss G; Schäfer K
    Cardiovasc Res; 2016 Aug; 111(3):204-16. PubMed ID: 27207947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac Disease Alters Myocardial Tissue Levels of Epoxyeicosatrienoic Acids and Key Proteins Involved in Their Biosynthesis and Degradation.
    Aliwarga T; Dinh JC; Heyward S; Prasad B; Gharib SA; Lemaitre RN; Sotoodehnia N; Totah RA
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.
    Murphy KA; Harsch BA; Healy CL; Joshi SS; Huang S; Walker RE; Wagner BM; Ernste KM; Huang W; Block RC; Wright CD; Tintle N; Jensen BC; Wells QS; Shearer GC; O'Connell TD
    Cardiovasc Res; 2022 Mar; 118(4):1061-1073. PubMed ID: 33752243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial overexpression of human CYP2J2 (Tie2-CYP2J2 Tr) modulates cardiac oxylipin profiles and enhances coronary reactive hyperemia in mice.
    Hanif A; Edin ML; Zeldin DC; Morisseau C; Falck JR; Nayeem MA
    PLoS One; 2017; 12(3):e0174137. PubMed ID: 28328948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of cytochrome P450 oxidoreductase enhances metabolism and DNA adduct formation of benzo[a]pyrene in Hepa1c1c7 cells.
    Reed L; Jarvis IWH; Phillips DH; Arlt VM
    Mutagenesis; 2019 Dec; 34(5-6):413-420. PubMed ID: 31612222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cytochrome P450 reductase (POR) expression in hepatoma cells replicates the hepatic lipidosis observed in hepatic POR-null mice.
    Porter TD; Banerjee S; Stolarczyk EI; Zou L
    Drug Metab Dispos; 2011 Jun; 39(6):966-73. PubMed ID: 21368239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hepatic phenotype and changes in gene expression in cytochrome P450 reductase (POR) null mice.
    Wang XJ; Chamberlain M; Vassieva O; Henderson CJ; Wolf CR
    Biochem J; 2005 Jun; 388(Pt 3):857-67. PubMed ID: 15717863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.